Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.
Frequently asked questions
What sector does Intrasense SA (ALINS) operate in?
Intrasense SA belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Intrasense SA (ALINS) current stock price?
As of the latest data, Intrasense SA stock price is €0.22, with a previous close of €0.21. Intrasense SA gained €0.01 in the last trading session, representing a 4.76% increase.
What is Intrasense SA (ALINS) current market capitalization?
Intrasense SA market cap is approximately 11.59 million.
What is Intrasense SA (ALINS) Earnings Per Share (EPS)?
The trailing EPS is -€20.51, and the forward EPS is -€0.05.
Does Intrasense SA (ALINS) pay dividends?
No. Intrasense SA does not pay a dividend.
What is Intrasense SA (ALINS) beta (volatility) score?
Intrasense SA has a beta of 0.483, indicating lower volatility than the overall market.
